Cargando…

Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein

The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Lohmann, Stephanie, Grigoletto, Jessica, Bernis, Maria Eugenia, Pesch, Verena, Ma, Liang, Reithofer, Sara, Tamgüney, Gültekin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867857/
https://www.ncbi.nlm.nih.gov/pubmed/35209932
http://dx.doi.org/10.1186/s40478-022-01327-6
_version_ 1784656139421483008
author Lohmann, Stephanie
Grigoletto, Jessica
Bernis, Maria Eugenia
Pesch, Verena
Ma, Liang
Reithofer, Sara
Tamgüney, Gültekin
author_facet Lohmann, Stephanie
Grigoletto, Jessica
Bernis, Maria Eugenia
Pesch, Verena
Ma, Liang
Reithofer, Sara
Tamgüney, Gültekin
author_sort Lohmann, Stephanie
collection PubMed
description The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential causality lacks mechanistic evidence. We investigated the long-term effects of ischemic stroke on pathogenesis in hemizygous TgM83 mice, which express human α-synuclein with the familial A53T mutation without developing any neuropathology or signs of neurologic disease for more than 600 days. We induced transient focal ischemia by middle cerebral artery occlusion in 2-month-old TgM83(+/−) mice and monitored their behavior and health status for up to 360 days post surgery. Groups of mice were sacrificed at 14, 30, 90, 180, and 360 days after surgery for neuropathological analysis of their brains. Motor deficits first appeared 6 months after focal ischemia and worsened until 12 months afterward. Immunohistochemical analysis revealed ischemia-induced neuronal loss in the infarct region and astrogliosis and microgliosis indicative of an inflammatory response, which was most pronounced at 14 days post surgery. Infarct volume and inflammation gradually decreased in size and severity until 180 days post surgery. Surprisingly, neuronal loss and inflammation were increased again by 360 days post surgery. These changes were accompanied by a continuous increase in α-synuclein aggregation, its neuronal deposition, and a late loss of dopaminergic neurons in the substantia nigra, which we detected at 360 days post surgery. Control animals that underwent sham surgery without middle cerebral artery occlusion showed no signs of disease or neuropathology. Our results establish a mechanistic link between ischemic stroke and Parkinson’s disease and provide an animal model for studying possible interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01327-6.
format Online
Article
Text
id pubmed-8867857
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88678572022-02-25 Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein Lohmann, Stephanie Grigoletto, Jessica Bernis, Maria Eugenia Pesch, Verena Ma, Liang Reithofer, Sara Tamgüney, Gültekin Acta Neuropathol Commun Research The etiology of Parkinson’s disease is poorly understood and is most commonly associated with advancing age, genetic predisposition, or environmental toxins. Epidemiological findings suggest that patients have a higher risk of developing Parkinson’s disease after ischemic stroke, but this potential causality lacks mechanistic evidence. We investigated the long-term effects of ischemic stroke on pathogenesis in hemizygous TgM83 mice, which express human α-synuclein with the familial A53T mutation without developing any neuropathology or signs of neurologic disease for more than 600 days. We induced transient focal ischemia by middle cerebral artery occlusion in 2-month-old TgM83(+/−) mice and monitored their behavior and health status for up to 360 days post surgery. Groups of mice were sacrificed at 14, 30, 90, 180, and 360 days after surgery for neuropathological analysis of their brains. Motor deficits first appeared 6 months after focal ischemia and worsened until 12 months afterward. Immunohistochemical analysis revealed ischemia-induced neuronal loss in the infarct region and astrogliosis and microgliosis indicative of an inflammatory response, which was most pronounced at 14 days post surgery. Infarct volume and inflammation gradually decreased in size and severity until 180 days post surgery. Surprisingly, neuronal loss and inflammation were increased again by 360 days post surgery. These changes were accompanied by a continuous increase in α-synuclein aggregation, its neuronal deposition, and a late loss of dopaminergic neurons in the substantia nigra, which we detected at 360 days post surgery. Control animals that underwent sham surgery without middle cerebral artery occlusion showed no signs of disease or neuropathology. Our results establish a mechanistic link between ischemic stroke and Parkinson’s disease and provide an animal model for studying possible interventions. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01327-6. BioMed Central 2022-02-24 /pmc/articles/PMC8867857/ /pubmed/35209932 http://dx.doi.org/10.1186/s40478-022-01327-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lohmann, Stephanie
Grigoletto, Jessica
Bernis, Maria Eugenia
Pesch, Verena
Ma, Liang
Reithofer, Sara
Tamgüney, Gültekin
Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
title Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
title_full Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
title_fullStr Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
title_full_unstemmed Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
title_short Ischemic stroke causes Parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
title_sort ischemic stroke causes parkinson’s disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867857/
https://www.ncbi.nlm.nih.gov/pubmed/35209932
http://dx.doi.org/10.1186/s40478-022-01327-6
work_keys_str_mv AT lohmannstephanie ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein
AT grigolettojessica ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein
AT bernismariaeugenia ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein
AT peschverena ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein
AT maliang ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein
AT reithofersara ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein
AT tamguneygultekin ischemicstrokecausesparkinsonsdiseaselikepathologyandsymptomsintransgenicmiceoverexpressingalphasynuclein